Skip to main content

Table 4 Best tumor responses for patients with unresectable hepatocellular carcinoma who underwent either HAIC or TACE

From: Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

Response

HAIC group [cases (%)]

TACE group [cases (%)]

P

Objective response

20 (54.1)

4 (9.8)

< 0.001

Disease control

31 (83.8)

21 (52.5)

0.004

 Complete response

0

0

1.000

 Partial response

20 (52.6)

4 (9.8)

< 0.001

 Stable disease

11 (28.9)

17 (41.5)

0.347

Progressive disease

6 (15.8)

19 (46.3)

0.004

Not evaluable

1 (2.6)

1 (2.4)

 
  1. HAIC hepatic artery infusion chemotherapy; TACE transarterial chemoembolization
  2. P values were calculated using a two-sided Chi square test